Biggest News Aggregation in the World
๐Ÿ“ฐ Nih News

Page 464 - Nih News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nih. Real-time updates on events, politics, business and more.

NIH experts discuss post-acute COVID-19

HIN Many people who have COVID-19 make a full recovery and return to their baseline state of health; however, some people have symptoms or other sequelae weeks or months after initial SARS-CoV-2 infection. These heterogeneous symptoms were the subject of the virtual โ€œWorkshop on Post-acute Sequelae of COVID-19โ€ hosted on Dec. 2 and 4, 2020, by the National Institute of Allergy and Infectious Diseases (NIAID), in collaboration with other institutes and centers of the National Institutes of H...
Emily Erbelding National Institute Of Allergy National Institutes Of Health Division Of Microbiology Post Acute Sequelae National Institute

NIH trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins

HIN A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun. The Phase 2 trial, called the COVID-19 anti-CD14 Treatment Trial (CaTT), is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The laboratory-created monoclo...
Vanderbilt University United States Foster City Markm Wurfel Thomasr Martin Anthonys Fauci

ULM's Dr. Seetharama Jois Receives $1.65 Million For Lung Cancer Research

University of Louisiana Monroe The National Institutes of Health awarded $1.65 million to fund cancer research being done by Seetharama Jois, Ph.D., a professor of Medicinal Chemistry at the School of Basic Pharmaceutical and Toxicological Sciences at the University of Louisiana Monroe College of Pharmacy. ย ย  The research will be carried out in collaboration with Yong-Yu Liu, M.D., Ph.D., a cancer pharmacologist at the ULM College of Pharmacy, and a lung-cancer researcher from the Mayo Clin...
United States Johnw Sutherlin Yong Yu Liu Seetharama Jois Office Of Sponsored Programs National Institutes Of Health
Source: kedm.org

Research: Better understanding of fundamental cell behavior can improve drug development

Date Time Research: Better understanding of fundamental cell behavior can improve drug development Pioneering research from Vanderbilt scientists shows that cells respond differently to acute stress than to gradual stress. The findings establish an entirely new way to look at cell-to-cell communication, or signaling, and may fundamentally change how biomedical researchers study cells. Alexander Thiemicke Gregor Neuert Research led by Alexander Thiemicke, former graduate student in chemical and ...
United States Hossein Jashnsaz Alexander Thiemicke Gregor Neuert Amanda Johnson Gregor Neuert Alexander Thiemicke

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

COVID-19 Reported as Third Leading Cause of Death in 2020 in the U.S. -- Occupational Health & Safety

Federal health researchers report the study from the past year. By Shereen Hashem Apr 02, 2021 Following heart disease and cancer, COVID-19 was officially the third leading cause of death in 2020. This displaced unintentional injuries as the usual third place spot, federal health researchers reported. Coronavirus took 345,323 lives of Americans solely last year. According to the National Center for Health Statistics, in about 30,000 additional cases, death certificates cited COVID-19, however, ...
United States Robert Anderson Shereen Hashem National Center Editor For Occupational Health Safety Health Statistics

Remarks by President Biden and Prime Minister Martin of Ireland Before Virtual Bilateral Meeting

1:20 P.M. EDT PRESIDENT BIDEN: Iโ€™m going to make a brief opening statement about a current thing going on in the United States here, and that is the shooting down in Atlanta where eight people were killed and โ€” seven women, six of Asian American background. And I was just, on the telephone, briefed by the Attorney General of the United States and the Director of the FBI. And the investigation is ongoing and the question of motivation is still to be determined. But whatever the motivation ...
United States Capitol District Of Columbia United States United Kingdom White House County Louth

Fierce Pharma Asia—Takeda's Maverick buyout; Brii COVID antibodies' trial halt; Dr. Reddy's generic Lipitor recall

Takeda, Brii Biosciences and Dr. Reddys Laboratories made our news this week. (Google) Takeda is buying its partner Maverick Therapeutics for its T-cell engager platform. The NIH has ended a clinical study testing Brii Biosciences anti-coronavirus antibody cocktail in hospitalized patients. Dr. Reddys Laboratories is pulling a large volume of its generic Lipitor off U.S. pharmacy shelves due to impurities. And more. Takeda exercised an option to buy out Maverick Therapeutics as part of aย colla...
New Jersey United States Adar Poonawalla Brii Bioscience Eli Lilly World Bank

Viruses Mutate, But Treatments Are Static. Is There a Way to Change That?

Date Time Viruses Mutate, But Treatments Are Static. Is There a Way to Change That? There is a big, global problem: viruses such as HIV and COVID-19 mutate, but treatments for them donโ€™t. For more than 20 years, Leor Weinberger, PhD, has been thinking about how to make vaccines work more efficiently by being adaptive, rather than static. A human T cell (blue) is under attack by HIV (yellow), the virus that causes AIDS. Image by NIH โ€œWeโ€™re fighting biology with chemistry,โ€ said Weinberge...
Leor Weinberger Gladstone Center Cell Circuitry Pharmaceutical Chemistry Ute Bowes Distinguished Professor Therapeutic Interfering Particles

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science